>Unlike RoseTTAFold and AlphaFold2, scientists will not be able to run their own version of AlphaFold3, nor will the code underlying AlphaFold3 or other information obtained after training the model be made public. Instead, researchers will have access to an ‘AlphaFold3 server’, on which they can input their protein sequence of choice, alongside a selection of accessory molecules. [. . .] Scientists are currently restricted to 10 predictions per day, and it is not possible to obtain structures of proteins bound to possible drugs.
This is unfortunate. I wonder how long until David Baker's lab upgrades RoseTTAFold to catch up.
>Unlike RoseTTAFold and AlphaFold2, scientists will not be able to run their own version of AlphaFold3, nor will the code underlying AlphaFold3 or other information obtained after training the model be made public. Instead, researchers will have access to an ‘AlphaFold3 server’, on which they can input their protein sequence of choice, alongside a selection of accessory molecules. [. . .] Scientists are currently restricted to 10 predictions per day, and it is not possible to obtain structures of proteins bound to possible drugs.
This is unfortunate. I wonder how long until David Baker's lab upgrades RoseTTAFold to catch up.